Huiyu Pharmaceutical (688553): Increased investment in R&D drags down performance, and the product hierarchy continues to be enriched
Huiyu Pharmaceutical (688553) Company Brief Review Report: Performance Meets Expectations, Product Echelon Continues to Enrich
No Data
No Data